These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15580883)

  • 1. [Low HDL-cholesterol, high triglycerides--well known but often ignored].
    Benz R; Suter PM
    Praxis (Bern 1994); 2004 Nov; 93(46):1911-6. PubMed ID: 15580883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dyslipidemia management in patients with impaired glucose tolerance].
    Asano M; Yamada N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():538-42. PubMed ID: 15779437
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug clinics. Drug of the month. Atorvastatin (Lipitor)].
    Scheen AJ
    Rev Med Liege; 1998 Jun; 53(6):374-7. PubMed ID: 9713220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin.
    Singhal MK; Bhaskaran S; Szabo T; La Rosa R
    Perit Dial Int; 1999; 19(1):89-91. PubMed ID: 10201354
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.
    Demetriou D; Shabpar A; Böhmig G; Schmaldienst S; Hörl WH; Watschinger B
    Wien Klin Wochenschr; 2000 Apr; 112(8):358-61. PubMed ID: 10849941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes.
    Wägner AM; Ordóñez-Llanos J; Jorba O; Pérez A
    Metabolism; 2004 Nov; 53(11):1516. PubMed ID: 15558848
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of atorvastatin (liptonorm) on indicators of the lipid spectrum of blood in patients with the metabolic syndrome].
    Vasil'eva LV; Lakhin DI
    Adv Gerontol; 2010; 23(2):281-4. PubMed ID: 21033384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia.
    Liamis G; Kakafika A; Bairaktari E; Miltiadous G; Tsimihodimos V; Goudevenos J; Achimastos A; Elisaf M
    Curr Med Res Opin; 2002; 18(3):125-8. PubMed ID: 12094821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Last fall I began taking daily doses of 1,500 mg of niacin, in addition to the 40 mg of Lipitor I've been taking for several years. Within six months, my LDL and triglycerides were down significantly and my HDL was higher. If my next bi-annual blood test shows the same types of results, should I discontinue the Lipitor and niacin?
    Heart Advis; 2008 Sep; 11(9):8. PubMed ID: 19222150
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease.
    Santanu G; Suhrita P; Mookerjee S; Tania K; Mita S; Pramit G; Sharmila G; Miraj M; Debdutta M
    Indian Heart J; 2011; 63(5):434-7. PubMed ID: 23550422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E; Sarcinella R
    Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
    [No Abstract]   [Full Text] [Related]  

  • 12. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atorvastatin in treatment of patients with coronary heart disease and dislipidemiya and high general risk: efficiency and safety estimation. Design and main results of ATLANTIKA].
    Mareev VIu; Belenkov IuN; Oganov RG; Barbik-Zhagar B
    Kardiologiia; 2008; 48(11):4-13. PubMed ID: 19076074
    [No Abstract]   [Full Text] [Related]  

  • 14. Increasing HDL Cholesterol Levels.
    Brewer HB
    N Engl J Med; 2004 Apr; 350(15):1491-4. PubMed ID: 15071124
    [No Abstract]   [Full Text] [Related]  

  • 15. A statin for a patient with hyperlipidemia and hepatitis C?
    Nash DT
    Postgrad Med; 2004 May; 115(5):86. PubMed ID: 15171081
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid disorders.
    Kole LA
    JAAPA; 2009 Nov; 22(11):54-5. PubMed ID: 19999177
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS
    Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statins.
    Devroey D; Velkeniers B; Duquet W; Betz W
    Acta Cardiol; 2003 Jun; 58(3):179-84. PubMed ID: 12846506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.